Abstract
The goal of this book is to provide a guide on modern day drug development in psychiatry. However, in order to understand current practices in drug development, it is important to first understand the history of psychiatry including early attempts at drug discovery and develoment. The early history of psychiatry is mired with the use of inhumane experimental treatments and the institutionalization of patients in asylums. Some of the earliest drugs used in these asylums were meant to sedate patients rather than treat underlying mental disorders. The earliest identified drugs treating mental disorders were born out of serendipitous discoveries which later led to their clinical effects being demonstrated through clinical trials and case studies. This is evident from the history of chlorpromazine, monoamine oxidase inhibitors, tricyclic antidepressants, lithium, and others. We discuss in detail about each of these psychotropic drugs, the events leading up to their discovery, and their role in formulating the biological basis of mental disorders including schizophrenia, depression, and bipolar disorder. Psychiatry, it seems has worked its way backwards from first identifying treatments before understanding the biological basis of mental disorders, in a sharp contrast to the other fields of medicine. With our growing understanding of the etiopathogenesis of mental disorders, drug development in psychiatry is evolving to develop treatments that target the underlying physiology of mental disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Binder DK, Schaller K, Clusmann H. The seminal contributions of Johann-Christian Reil to anatomy, physiology, and psychiatry. Neurosurgery. 2007;61(5):1091–6. https://doi.org/10.1227/01.neu.0000303205.15489.23.
Hirshbein L. The American Psychiatric Association and the history of psychiatry. Hist Psychiatry. 2011;22(3):302–14. https://doi.org/10.1177/0957154X10389744.
Pelletier J-F, Davidson L. A l’origine meme de la psychiatrie comme nouvelle specialite medicale: le partenariat Pinel-Pussin. Sante Ment Que. 2015;40(1):19–34.
Dix D. “I Tell What I Have Seen” – The Reports of Asylum Reformer Dorothea Dix. Am J Public Health. 2006;96(4):622–4. https://doi.org/10.2105/AJPH.96.4.622.
Conrad JA. A black and white history of psychiatry in the United States. J Med Humanit. 2022;43(2):247–66. https://doi.org/10.1007/s10912-020-09650-6.
Terrier LM, Lévêque M, Amelot A. Brain lobotomy: a historical and moral dilemma with no alternative? World Neurosurg. 2019;132:211–8. https://doi.org/10.1016/j.wneu.2019.08.254.
Freeman W. Lobotomy in limbo? Am J Psychiatry. 1972;128(10):1315–6. https://doi.org/10.1176/ajp.128.10.1315.
Clarke P. Hip hip hooray, ECT turns 80! Australas Psychiatry. 2019;27(1):53–5. https://doi.org/10.1177/1039856218815753.
Carlsson A. Reflections on the history of psychopharmacology. Psychopharmacol Ser. 1988;5:3–11. https://doi.org/10.1007/978-3-642-73280-5_1.
Braslow JT, Marder SR. History of psychopharmacology. Annu Rev Clin Psychol. 2019;15:25–50.
Boyd-Kimball D, Gonczy K, Lewis B, Mason T, Siliko N, Wolfe J. Classics in chemical neuroscience: chlorpromazine. ACS Chem Neurosci. 2019;10(1):79–88. https://doi.org/10.1021/acschemneuro.8b00258.
AlanA B, MikeF H, López-Muñoz F. Toward standardized usage of the word serendipity in the historiography of psychopharmacology. J Hist Neurosci. 2010;19(3):253–70. https://doi.org/10.1080/09647040903188205.
Tourney G. History of biological psychiatry in America. Am J Psychiatry. 1969;126(1):29–42. https://doi.org/10.1176/ajp.126.1.29.
Fangmann P, Assion HJ, Juckel G, González CÁ, López-Muñoz F. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. J Clin Psychopharmacol. 2008;28(1):1–4. https://doi.org/10.1097/jcp.0b013e3181627b60.
Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563–86. https://doi.org/10.2174/138161209788168001.
Foley PB. Dopamine in psychiatry: a historical perspective. J Neural Transm. 2019;126(4):473–9. https://doi.org/10.1007/s00702-019-01987-0.
Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23(1):1–21. https://doi.org/10.1037/a0038550.
Chockalingam R, Gott BM, Conway CR. Tricyclic antidepressants and monoamine oxidase inhibitors: are they too old for a new look? Handb Exp Pharmacol. 2019;250:37–48. https://doi.org/10.1007/164_2018_133.
Brown WA, Rosdolsky M. The clinical discovery of imipramine. Am J Psychiatry. 2015;172(5):426–9. https://doi.org/10.1176/appi.ajp.2015.14101336.
Leon AC. Evolution of psychopharmacology trial design and analysis: six decades in the making. J Clin Psychiatry. 2011;72(03):331–40. https://doi.org/10.4088/JCP.10r06669.
Aronson JK, Green AR. Me-too pharmaceutical products: history, definitions, examples, and relevance to drug shortages and essential medicines lists. Br J Clin Pharmacol. 2020;86(11):2114–22. https://doi.org/10.1111/bcp.14327.
Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122(5):509–22. https://doi.org/10.1176/ajp.122.5.509.
Bunney WE, Davis JM. Norepinephrine in depressive reactions. A review Arch Gen Psychiatry. 1965;13(6):483–94. https://doi.org/10.1001/archpsyc.1965.01730060001001.
Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60(Suppl 4):4–11; discussion 12–3.
López-Muñoz F, Shen WW, D’Ocon P, Romero A, Álamo C. A history of the pharmacological treatment of bipolar disorder. Int J Mol Sci. 2018;19(7):2143. https://doi.org/10.3390/ijms19072143.
Ruffalo ML. A brief history of lithium treatment in psychiatry. Prim Care Companion CNS Disord. 2017;19(5):27325. https://doi.org/10.4088/PCC.17br02140.
Cade JF. Lithium salts in the treatment of psychotic excitement. 1949. Bull World Health Organ. 2000;78(4):518–20.
Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17(4):250–60. https://doi.org/10.1136/jnnp.17.4.250.
Johnson G, Gershon S, Hekimian LJ. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Compr Psychiatry. 1968;9(6):563–73. https://doi.org/10.1016/s0010-440x(68)80053-7.
Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry J Ment Sci. 1971;119(550):267–76. https://doi.org/10.1192/bjp.119.550.267.
Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry. 1975;32(1):34–42. https://doi.org/10.1001/archpsyc.1975.01760190036004.
Hoffman. The Discovery of LSD. Accessed April 4, 2022. https://catbull.com/alamut/Bibliothek/HOFMANN%20Albert/discovery/lsd.htm.
Farr CB. Benjamin rush and American psychiatry. 1944. Am J Psychiatry. 1994;151(6 Suppl):64–73. https://doi.org/10.1176/ajp.151.6.64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wadhwa, A. (2023). The History of Drug Development in Psychiatry: A Lesson in Serendipity. In: Macaluso, M., Preskorn, S.H., Shelton, R.C. (eds) Drug Development in Psychiatry. Advances in Neurobiology, vol 30. Springer, Cham. https://doi.org/10.1007/978-3-031-21054-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-21054-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-21053-2
Online ISBN: 978-3-031-21054-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)